← Leaderboards
Will Clifton
Polyvascular Corporation
$2,416,359
Attributed
$2,416,359
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2021–22$2M$1.5M$1M$500K$0
'21
'22
Funding mix
By agency
NIH$2,416,359 · 1
By mechanism
R44$2,416,359 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Minimally Invasive”
- Shadi Dayeh · University Of California, San Diego$9,482,559
- Balasubramani K Goundappa · University Of Pittsburgh At Pittsburgh$8,538,627
- Jessica Alber · University Of Rhode Island$8,348,817
- Anna Fernandez · Booz Allen Hamilton$6,707,503
- Samirkumar Patel · Moonlight Therapeutics, Inc.$5,797,887
- Beverly Tang · Starlight Cardiovascular, Inc.$5,746,454
Research focus
Minimally InvasiveLungMetalsHeartImmune ResponseInguinal RegionCongenital Heart DefectsHeart ValvesDisadvantagedFamily BurdenAdultCardiac Surgery ProceduresBiologicalCategoriesAdolescentCessation Of LifeCongenital Heart DisorderChildChildhoodCadaverEmotionalFailureCongenital AbnormalityOperative Surgical Procedures
Grant awards (6)
Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children$989,945
R44 · FY2022 · HL · contact PI
Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children$120,938
R44 · FY2022 · HL · contact PI
Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children$120,938
R44 · FY2022 · HL · contact PI
Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children$1,007,115
R44 · FY2021 · HL · contact PI
Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children$95,548
R44 · FY2021 · HL · contact PI
Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children$81,875
R44 · FY2021 · HL · contact PI